Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2195694)

Published in J Exp Med on November 15, 1999

Authors

L Diaw1, D Siwarski, A Coleman, J Kim, G M Jones, G Dighiero, K Huppi

Author Affiliations

1: Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Articles cited by this

Somatic generation of antibody diversity. Nature (1983) 28.06

Multicolor spectral karyotyping of human chromosomes. Science (1996) 7.65

Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49

Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49

Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78

Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol (1982) 4.21

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96

Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell (1982) 3.86

Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature (1999) 3.86

Antigen-binding myeloma proteins of mice. Adv Immunol (1977) 3.54

Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50

Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00

B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78

Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60

V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science (1997) 2.58

Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 2.56

Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol (1983) 2.53

Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity (1995) 2.40

DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A (1982) 2.36

Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chains. J Exp Med (1984) 2.33

Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst (1994) 2.24

V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling. Nature (1998) 1.97

Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement. Proc Natl Acad Sci U S A (1985) 1.95

Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90

Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis (1992) 1.88

Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science (1996) 1.80

Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties. J Lab Clin Med (1961) 1.78

Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur J Immunol (1986) 1.78

How immunoglobulin V kappa genes rearrange. J Immunol (1987) 1.68

Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62

Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell (1981) 1.60

Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev (1994) 1.58

Lack of feedback inhibition of V kappa gene rearrangement by productively rearranged alleles. J Exp Med (1991) 1.46

A new Igk-V gene family in the mouse. Immunogenetics (1990) 1.43

Frequent lambda light chain gene rearrangement and expression in a Ly-1 B lymphoma with a productive kappa chain allele. Proc Natl Acad Sci U S A (1986) 1.42

Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol (1995) 1.31

B-cell lineages exist in the mouse. Immunol Today (1993) 1.30

Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29

Plasmacytomas with more than one immunoglobulin kappa mRNA: implications for allelic exclusion. Proc Natl Acad Sci U S A (1981) 1.24

Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines. EMBO J (1992) 1.21

Ig lambda-producing B cells do not show feedback inhibition of gene rearrangement. J Immunol (1988) 1.19

Functional and pseudogenes are similarly organized and may equally contribute to the extensive antibody diversity of the IgVHII family. EMBO J (1985) 1.15

Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol (1994) 1.14

Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup. J Immunol (1987) 1.13

kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire. J Exp Med (1995) 1.11

Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood (1995) 1.11

Pvt-1 transcripts are found in normal tissues and are altered by reciprocal(6;15) translocations in mouse plasmacytomas. Proc Natl Acad Sci U S A (1990) 1.09

Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood (1998) 1.06

Ongoing V kappa-J kappa recombination after formation of a productive V kappa-J kappa coding joint. Eur J Immunol (1992) 1.06

Secondary V(D)J recombination in B-1 cells. Nature (1999) 1.06

Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line. J Exp Med (1989) 1.04

A shared kappa reciprocal fragment and a high frequency of secondary Jk5 rearrangements among influenza hemagglutinin specific B cell hybridomas. J Immunol (1991) 1.01

Sequences of variable regions of hybridoma antibodies to alpha (1----6) dextran in BALB/c and C57BL/6 mice. J Immunol (1985) 0.98

Structural and affinity studies of IgM polyreactive natural autoantibodies. J Immunol (1997) 0.95

A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol (1994) 0.94

Structural characterization of the second major cross-reactive idiotype group of human rheumatoid factors. Association with the VH4 gene family. Arthritis Rheum (1990) 0.90

Characterization of allelic V kappa-1 region genes in inbred strains of mice. J Immunol (1989) 0.89

A single pre-B cell can give rise to antigen-specific B cells that utilize distinct immunoglobulin gene rearrangements. J Exp Med (1990) 0.88

Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia (1994) 0.86

B cell development and differentiation. Curr Opin Immunol (1997) 0.86

Autoimmunity and B-cell malignancies. Hematol Cell Ther (1998) 0.82

Natural autoantibodies. Adv Exp Med Biol (1994) 0.79

Expression of lambda and kappa genes can occur in all B cells and is initiated around the same pre-B-cell developmental stage. Dev Immunol (1994) 0.79

Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. Br J Haematol (1998) 0.77

Articles by these authors

Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31

Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A (1994) 8.06

Real-time prediction of hand trajectory by ensembles of cortical neurons in primates. Nature (2000) 7.29

A novel family of divergent seven-transmembrane proteins: candidate odorant receptors in Drosophila. Neuron (1999) 6.03

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1984) 5.49

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med (1995) 4.65

Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25

Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol (1990) 4.23

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22

Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol (1982) 4.21

The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med (1995) 4.03

The itinerary of a vesicle component, Aut7p/Cvt5p, terminates in the yeast vacuole via the autophagy/Cvt pathways. J Biol Chem (2000) 3.97

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96

Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90

Murine T-cell receptor mutants with deletions of beta-chain variable region genes. Proc Natl Acad Sci U S A (1986) 3.76

Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol (2000) 3.64

Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54

Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39

Calmodulin target database. J Struct Funct Genomics (2000) 3.20

Cvt19 is a receptor for the cytoplasm-to-vacuole targeting pathway. Mol Cell (2001) 3.12

Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11

Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol (1999) 3.04

Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92

Multicolour spectral karyotyping of mouse chromosomes. Nat Genet (1996) 2.90

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (2001) 2.85

Soft tissue cephalometric analysis: diagnosis and treatment planning of dentofacial deformity. Am J Orthod Dentofacial Orthop (1999) 2.81

Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78

Are patients with abnormal cervical smears adequately managed? Br Med J (Clin Res Ed) (1984) 2.78

Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) (2007) 2.67

Muscular control of landing from unexpected falls in man. J Physiol (1971) 2.62

Observations on the control of stepping and hopping movements in man. J Physiol (1971) 2.55

Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol (1983) 2.53

Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53

Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet (1993) 2.47

Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology (2009) 2.47

Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46

The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today (1994) 2.44

Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39

Design of biomimetic fibrillar interfaces: 1. Making contact. J R Soc Interface (2004) 2.38

Chimeric transcripts with an open reading frame are generated as a result of translocation to the Pvt-1 region in mouse B-cell tumors. Int J Cancer (1994) 2.34

Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174. Proc Natl Acad Sci U S A (1972) 2.29

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24

Ultrabithorax regulates genes at several levels of the wing-patterning hierarchy to shape the development of the Drosophila haltere. Genes Dev (1998) 2.22

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21

A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci U S A (1995) 2.20

High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17

Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood (2000) 2.16

Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13

Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci U S A (1997) 2.11

An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy (2004) 2.10

Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10

Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10

Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores. Eur J Neurol (2011) 2.09

Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09

Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin. J Urol (2000) 2.07

Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation (1997) 2.06

Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol (2002) 2.05

Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol (1990) 2.03

Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood (1999) 2.02

Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect (2007) 2.00

An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis. J Infect Dis (2000) 1.99

Apg2 is a novel protein required for the cytoplasm to vacuole targeting, autophagy, and pexophagy pathways. J Biol Chem (2001) 1.99

The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev (1998) 1.99

Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol (2003) 1.97

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97

Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology (1993) 1.92

Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol (2000) 1.90

The determination of the order of lysine-containing tryptic peptides of proteins by diagonal paper electrophoresis. A carboxyl-terminal sequence for pepsin. Eur J Biochem (1967) 1.87

Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86

Correlated errors in biased surrogates: study designs and methods for measurement error correction. Stat Med (2005) 1.85

The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun (2001) 1.84

Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol (1999) 1.84

Prediction of novel and analogous folds using fragment assembly and fold recognition. Proteins (2005) 1.84

Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J Virol (1994) 1.81

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81

Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2001) 1.81

Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77

Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77

Visual and instrumental colorimetric assessments of small color differences on translucent dental porcelain. J Dent Res (1989) 1.77

Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J Biol Chem (2000) 1.75

Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75

The nitrogenase FeMo-cofactor and P-cluster pair: 2.2 A resolution structures. Science (1993) 1.74

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood (2001) 1.74

Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol (2006) 1.73

Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia (2007) 1.73

Electrical conduction through poly(dA)-poly(dT) and poly(dG)-poly(dC) DNA molecules. Phys Rev Lett (2001) 1.72

Evidence for autoregulation of cystathionine gamma-synthase mRNA stability in Arabidopsis. Science (1999) 1.72

Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68

Physician fees and procedure intensity: the case of cesarean delivery. J Health Econ (1999) 1.68

Multiple sets of basal factors initiate transcription by RNA polymerase II. J Biol Chem (1994) 1.68

Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol (2001) 1.68

Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol (2002) 1.67

G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet (1985) 1.67

Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev (1995) 1.66

Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J Biol Chem (1991) 1.66

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology (2001) 1.65